Preclinical development of an oral anti-
Journal
Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086
Informations de publication
Date de publication:
13 03 2019
13 03 2019
Historique:
received:
17
05
2018
accepted:
19
10
2018
entrez:
15
3
2019
pubmed:
15
3
2019
medline:
23
2
2020
Statut:
ppublish
Résumé
There is an urgent global need for a safe macrofilaricide drug to accelerate elimination of the neglected tropical diseases onchocerciasis and lymphatic filariasis. From an anti-infective compound library, the macrolide veterinary antibiotic, tylosin A, was identified as a hit against
Identifiants
pubmed: 30867321
pii: 11/483/eaau2086
doi: 10.1126/scitranslmed.aau2086
pii:
doi:
Substances chimiques
Macrolides
0
Tylosin
YEF4JXN031
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical Research Council
ID : MC_PC_16052
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L018756/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R025401/1
Pays : United Kingdom
Organisme : National Centre for the Replacement, Refinement and Reduction of Animals in Research
ID : NC/M00175X/1
Pays : United Kingdom
Informations de copyright
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).